APPLICATION
ANDA215975
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
LETROZOLE;VRIBOCICLIB SUCCINATENone (Tentative Approval)
LETROZOLE 200MG, RIBOCICLIB SUCCINATE 2.5MG · TABLET · ORAL
Approval history
2023-05-01UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.